Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin, 5-FU, and Radiation for Esophageal Cancer
NCT00086996Phase 2Completed
- Sponsor
- SWOG Cancer Research Network
- Start
- Sep 2004
- Primary completion
- Aug 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in esophageal adenocarcinoma (EAC), gastroesophageal junction adenocarcinoma, sponsored by SWOG Cancer Research Network. Started Sep 2004; status: completed.
02
Drugs
oxaliplatin
03
Conditions
esophageal adenocarcinoma (EAC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT00086996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00086996.